Videum
 
 
Touch Medical Media
Touch Medical Media

Touch Medical Media

Leading the Debate on the Advances in Healthcare

0 Followers
Share
240

ASH 2016 Will Donnellan Interview

Dr Will Donnellan reviews the challenges in chimeric antigen receptor (CAR) T-cell therapy for acute myeloid leukemia (AML). He also gives us his thoughts on the lack of randomized trials for patients with refractory AML and discusses emerging antibody-based therapies.

Duration: 06:15
Licence: CC - Attribution
Original Language: English
Published: 12/12/2016
Diseases and Conditions: Multiple Myeloma
Format: Conference / Interviews / KOL

Other videos in this channel

 

Related Videos

ASH 2016 Will Donnellan Interview

Comments (0)

Login to add your comment
Be the first to comment!